Among the companies with shares expected to actively trade in
Tuesday's session are Cummins Inc. (CMI), Actavis PLC (ACT) and
Huntsman Corp. (HUN).
Cummins' third-quarter earnings edged up 0.9% as the supplier of
engines for heavy-duty trucks reported weaker revenue growth than
expected and the cut its full-year sales outlook. Shares slipped
5.5% to $127.55 premarket.
Actavis' third-quarter earnings fell 14%, despite double-digit
revenue growth, as the generic drug maker was hit by higher
acquisition-related charges and other items. The company raised its
per-share earnings estimate for the year. Shares climbed 4.4% to
$152.25 premarket.
Huntsman Corp.'s (HUN) third-quarter earnings fell 45% as the
chemical manufacturer logged an increase in operating expenses and
weaker margins, though revenue improved slightly more than
expected. Shares edged up 2.5% to $22.25 premarket.
After giving a downbeat revenue forecast three months ago, Xylem
Inc.'s (XYL) results weren't nearly as bad as feared. But the water
firm during the summer saw a "strong performance in emerging
markets and better-than-expected activity in Europe." The cherry on
top is Xylem undoing some of July's cut to 2013 estimates. Shares
surged 11% to $32.20 premarket.
Archer Daniels Midland Co.'s (ADM) third-quarter revenue
declined, while its earnings more than doubled as an accounting
credit boosted the U.S. grain trader and processor's results. The
bottom line just missed expectations, sending shares down 2.1% to
$39 premarket.
LyondellBasell Industries N.V.'s (LYB) third-quarter earnings
edged up 0.8% as the plastics and chemicals company reported
stronger profits in its olefins and polyolefins segments, though
results were weaker in its intermediates and refining businesses.
Results missed estimates, sending shares down 2% premarket to
$74.
Vertex Pharmaceuticals Inc. (VRTX) plans to reduce its global
work force by 15% amid declines in the number of patients being
treated with its Incivek drug, as the company also reported that
its third-quarter loss widened and it cut its revenue view for the
year. Shares dropped 2.4% to $76 premarket.
Nutrisystem Inc.'s (NTRI) better-than-expected adjusted
third-quarter profit sent shares higher, as the weight-loss
products company also struck a cautiously optimistic tone about the
upcoming diet season. Shares climbed 9.2% to $16.40 in premarket
trading, as results for the period exceeded the muted expectations
Nutrisystem outlined in July.
Seagate Technology Inc.'s (STX) fiscal first-quarter earnings
fell 27%, pressured by sliding revenue at the data-storage company.
Shares fell 3.7% to $48 in premarket trading as results missed
expectations.
Tableau Software Inc.'s (DATA) third-quarter profit increased
more than sixfold driven by another surge in revenue. Revenue
jumped 90% to $61.1 million in the quarter as the company reported
growth in customer accounts. Shares of Tableau rose 10% to $69.50
premarket as the results beat expectations.
Michael Kors Holdings Ltd. (KORS) will replace NYSE Euronext
Inc. (NYX) in the S&P 500 after trading closes Friday as
IntercontinentalExchange Inc.'s (ICE) deal to acquire NYSE is
expected to close soon. Shares rose 3.3% to $78.90.
Watch List:
Aetna Inc.'s (AET) third-quarter earnings increased 4% as the
health insurer's revenue and membership rolls were boosted by its
acquisition of Coventry Health Care Inc., though the company also
posted lower underwriting margins. Adjusted earnings declined more
than expected.
Air Products & Chemicals Inc.'s (APD) fiscal fourth-quarter
earnings fell 1.2%, as the industrial-gas provider's posted weaker
revenue and was weighed down by discontinued operations. The
company gave a weak outlook for the new year and first quarter.
Apple Inc. (AAPL) sold 33.8 million iPhones in the September
quarter, up 26% from a year earlier, but not enough to prevent a
third consecutive quarterly decline in earnings.
AZZ Inc.'s (AZZ) President and Chief Executive David Dingus died
Sunday from medical complications related to pancreatic cancer, the
electrical-products and galvanizing-services company disclosed.
Those duties will be assumed by Chief Financial Officer Dana Perry
on an interim basis.
CVSL Inc. (CVSL) has offered to pay $16.75 a share to acquire
candle maker Blyth Inc. (BTH), according to Bloomberg, which cited
two people with knowledge of the matter. The offer is valued at
about $268 million.
Covidien PLC (COV) has stuck a deal to sell the company's
confluent surgical product line to Integra LifeSciences Holdings
Corp. (IART) for $235 million, unloading a line of soft-tissue
repair tools.
DineEquity Inc.'s (DIN) third-quarter income sank 69% after the
owner of the IHOP and Applebee's restaurant chains completed its
plans to sell off company-owned locations, while IHOP continued to
show strength, again posting an improvement in same-restaurant
sales. Results beat expectations.
General Growth Properties Inc. (GGP) swung to a third-quarter
profit amid fewer expenses. The company again raised its estimate
for full-year funds from operations--a key profitability measure
for real-estate investment trusts.
Hartford Financial Services Group Inc.'s (HIG) third-quarter
earnings soared as the insurer reported better-than-expected
revenue growth and the year-earlier period included a big loss
related to the sale of its individual life business.
HCP Inc.'s (HCP) third-quarter earnings increased 19% as the
senior-focused real-estate investment trust's rental revenue
continued to increase. Results beat views and the company also
slightly raised its full-year outlook for funds from
operations.
HealthSouth Corp.'s (HLS) third-quarter profit rose 24% while
the hospital operator experienced growth in revenue same-hospital
discharges.
Herbalife Ltd.'s (HLF) third-quarter profit rose 27% as the
nutritional-supplements maker posted a jump in world-wide
sales.
JetBlue Airways Corp. reported its (JBLU) third-quarter earnings
rose 58% and the U.S. discount carrier also unveiled changes in
plans to improve its fleet to more closely align with demand and
reduce costs. The plan includes deferring some aircraft and
converting others.
Pfizer Inc.'s (PFE) third-quarter earnings fell 19% as the
pharmaceutical company's sales weakened across most of its
businesses, particularly its primary care segment. The company
raised its the lower end of its per-share earnings estimate for the
year but cut the upper end of its previous revenue view.
Plum Creek Timber Co. (PCL) has agreed to acquire industrial
timber lands, related wind and mineral assets and an interest in
other properties from MeadWestvaco Corp. (MWV) in a $1.1 billion
deal as the real-estate investment trust also reported that its
third-quarter earnings rose 22%.
Riverbed Technology Inc.'s (RVBD) third-quarter profit slumped
85%, as the network-equipment maker reported sharply higher sales
and marketing expenses, offsetting an increase in sales across all
markets it serves.
U.S. Steel Corp. (X) swung to a steep third-quarter loss as the
steelmaker recorded a $1.8 billion write-down for its North
American flat-rolled and Texas operations. Excluding that charge,
U.S. Steel's adjusted loss for the period wasn't as severe as
analysts expected, though shipments again declined from year-ago
levels.
Valero Energy Corp.'s (VLO) third-quarter profit shrank 54% as
total expenses climbed 6.5%, masking a rise in revenue. Results
were better than feared.
Waste Management Inc.'s (WM) third-quarter earnings jumped 36%
as the waste-disposal company posted increased internal revenue
growth from yield and stronger margins, though it continued to face
headwinds in its recycling business. Results beat expectations.
Write to Lauren Pollock at lauren.pollock@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires